CClinicalTrials.gg
CompletedNCT07787598HIIT-LBPUpdated Aug 26, 2026

High-Intensity Interval Training in Young Women With Mechanical Low Back Pain

An interventional study of HIIT and low intensity training in Low Back Pain, sponsored by MTI University. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by MTI University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
Female
01

Study summary

This randomized controlled trial evaluated the effects of a 4-week high-intensity interval training (HIIT) program on pain, functional disability, body composition, cardiorespiratory fitness, and quality of life in young women with mechanical low back pain. Participants were randomly allocated to either a supervised HIIT cycling program or a control exercise program consisting of stretching and low- to moderate-intensity treadmill walking. Outcomes were assessed at baseline and after completion of the 4-week intervention.

Read the detailed description

This randomized controlled trial used a two-arm parallel-group design to investigate the effects of a 4-week high-intensity interval training (HIIT) program on pain, functional disability, body composition, cardiorespiratory fitness, and quality of life in young women with mechanical low back pain.

The study was conducted at the outpatient and physiotherapy clinics of MTI University. Ethical approval was obtained from the Institutional Review Board of MTI University (approval number REC/2111/MTI.PT/2411261), and the study was conducted in accordance with the principles of the Declaration of Helsinki. The trial was retrospectively registered on ClinicalTrials.gov because of administrative delays.

Eligible participants were women aged 20-38 years with mild-to-moderate nonspecific mechanical low back pain persisting for more than three months. Participants were screened according to predefined eligibility criteria. Exclusion criteria included pregnancy or lactation, recent surgery, secondary causes of low back pain, osteoporosis, osteoarthritis, sciatica, generalized neuromuscular disorders, structural deformities, fractures, conditions restricting physical activity, cardiovascular or respiratory conditions that could compromise exercise safety, autonomic dysfunction, and use of medications that could affect heart-rate responses.

Participants were randomly allocated to either the HIIT group or the control exercise group using a computer-generated random sequence with permuted blocks of 4 and 6. Randomization was stratified according to baseline pain severity (VAS ≤5 versus >5). Allocation concealment was maintained using sequentially numbered, sealed, opaque envelopes prepared by a researcher who was not involved in participant recruitment or outcome assessment. Due to the nature of the exercise interventions, participant blinding was not feasible.

The HIIT group participated in supervised cycling sessions three times per week for 4 weeks. Each session lasted approximately 30-40 minutes and included a warm-up, repeated high-intensity cycling intervals, recovery periods, and a cool-down. High-intensity intervals were performed at approximately 80% of maximum heart rate, with heart rate continuously monitored during training. Sessions were supervised by a licensed physiotherapist.

The control group participated in supervised low- to moderate-intensity exercise consisting of stretching and treadmill walking performed at approximately 40-60% of maximum heart rate. Exercise intensity was monitored using heart-rate monitoring.

Outcomes were assessed at baseline and after completion of the 4-week intervention. Pain intensity was assessed using the Visual Analog Scale (VAS). Functional disability was assessed using the Oswestry Disability Index (ODI). Body composition, including fat mass percentage and muscle mass, was assessed using bioelectrical impedance analysis. Cardiorespiratory fitness was assessed by measuring maximal oxygen uptake (VO₂ max) using cardiopulmonary exercise testing. Quality of life was assessed using the Quality-of-Life Scale (QOLS).

Adverse events were monitored throughout the supervised exercise sessions. Participants were instructed to report symptoms including dizziness, excessive fatigue, exacerbation of musculoskeletal pain, or cardiovascular discomfort.

Statistical analyses were conducted using SPSS. Data distribution was assessed before statistical analysis. Appropriate statistical tests were used to evaluate within-group changes and between-group differences. Effect sizes were calculated to quantify the magnitude of observed differences, and statistical significance was assessed using a two-sided p-value threshold of \<0.05.

02

Conditions studied

  • Low Back Pain

Browse trials for

Keywords

  • mechanical low back pain
  • HIIT
  • functional ability
  • body composition
  • VO₂ max
03

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

**Inclusion Criteria:**

  • Female participants aged 20 to 38 years.
  • Mild to moderate nonspecific low back pain persisting for more than 3 months.
  • Low back pain without an identifiable specific pathological cause.
  • Body mass index (BMI) between 18.5 and 34.9 kg/m².
  • Able to participate safely in the prescribed cycling exercise intervention.

**Exclusion Criteria:**

  • Pregnancy or lactation.
  • Recent surgery.
  • Any chronic medical condition that restricts physical activity or exercise participation.
  • Secondary causes of low back pain.
  • Osteoporosis.
  • Osteoarthritis.
  • Sciatica.
  • Generalized neuromuscular disorders.
  • Structural spinal deformities.
  • Vertebral or other relevant fractures.
  • Reliance on assistive walking devices.
  • Cardiovascular disease that could compromise safe participation in cycling exercise.
  • Respiratory disease that could compromise safe participation in cycling exercise.
  • Autonomic dysfunction, including diabetes mellitus.
  • Current use of medications known to affect heart rate variability, including beta-blockers or calcium channel blockers.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
67 participants (actual)

Study arms

  • Experimental
    The HIIT group

    participated in supervised cycling sessions lasting 30-40 minutes, three times per week, performed at intensities ranging from 80% to 90% of maximum heart rate (HRmax).

    Other: HIIT

  • Active comparator
    The control group

    performed supervised moderate- to low-intensity exercises, including stretching and treadmill walking at 40-60% HRmax, for 30-40 minutes, with heart rate monitoring to regulate exercise intensity.

    Other: low intensity training

Interventions

  • OtherHIIT

    participated in supervised cycling sessions lasting 30-40 minutes, three times per week, performed at intensities ranging from 80% to 90% of maximum heart rate (HRmax).

  • Otherlow intensity training

    performed supervised moderate- to low-intensity exercises, including stretching and treadmill walking at 40-60% HRmax, for 30-40 minutes, with heart rate monitoring to regulate exercise intensity.

05

What researchers measure

Primary outcomes

  1. Oswestry Disability Index (ODI)

    Functional disability was assessed using the Oswestry Disability Index (ODI), a validated self-reported questionnaire for assessing disability related to low back pain. Total scores range from 0 to 100, with higher scores indicating greater disability.

    Time frame: Baseline (pre-intervention) and immediately post-intervention at 4 weeks

  2. Visual Analog Scale (VAS)

    Pain intensity was assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.

    Time frame: Baseline (pre-intervention) and immediately post-intervention at 4 weeks

  3. Body Composition Parameters

    Body composition was assessed using bioelectrical impedance analysis with the InBody 700 system. The assessed parameters included percentage body fat and skeletal muscle mass.

    Time frame: Baseline (pre-intervention) and immediately post-intervention at 4 weeks

  4. Maximal Oxygen Uptake (VO₂ max)

    Cardiorespiratory fitness was assessed by measuring maximal oxygen uptake (VO₂ max) using the COSMED Quark CPET system during a graded exercise test. VO₂ max was expressed in mL/kg/min, with higher values indicating better cardiorespiratory fitness.

    Time frame: Baseline (pre-intervention) and immediately post-intervention at 4 weeks

  5. Quality of Life Scale (QOLS)

    Quality of life was assessed using the Quality of Life Scale (QOLS), a multidimensional instrument assessing physical, social, and psychological aspects of quality of life. Total scores range from 16 to 112, with higher scores indicating better quality of life.

    Time frame: Baseline (pre-intervention) and immediately post-intervention at 4 weeks

06

Study locations

1 site
  • MTI university
    Cairo, Egypt
07

Registry details

Key details

Study ID
NCT07787598
Lead sponsor
MTI University
Responsible party
Omnia Mohammed (Lecturer, Department of woman and Child Health, Faculty of Physical Therapy, Beni Suef University, Beni-Suef University) — Principal investigator
First posted
Aug 26, 2026
Start date
Nov 26, 2024
Primary completion
Nov 26, 2025
Completion
Jul 22, 2026
Last update
Aug 26, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion